Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Cardiac contractility modulation wikipedia , lookup
Electrocardiography wikipedia , lookup
Quantium Medical Cardiac Output wikipedia , lookup
Myocardial infarction wikipedia , lookup
Hypertrophic cardiomyopathy wikipedia , lookup
Heart arrhythmia wikipedia , lookup
Ventricular fibrillation wikipedia , lookup
Arrhythmogenic right ventricular dysplasia wikipedia , lookup
UNIVERSITY OF MALTA RESEARCH SEMINARS Abstract form Title: PHYSIOLOGICAL AND PHARMACOLOGICAL CHARACTERISATION OF A NOVEL SARCOLEMMAL ANIONIC BACKGROUND CONDUCTANCE (IAB) IN HEART Presenter: John Joseph Borg Contact address: Maltese Medicines Authority, 198 rue D’Argens Gzira, & Institute of Agriculture University of Malta Tel: 99261152 Fax: Email: [email protected]; [email protected] Presentation date: 29th November 2004 (approximately 200-250 words) Abstract Recently, a novel anionic background conductance (IAB) was identified in the rat heart and suggested to play a role in action potential duration (APD). The focus of the present work was to investigate the physiological relevance of this current by physiologically and pharmacologically characterising IAB in the guinea pig, a species with a ventricular action potential (AP) similar in profile to that of the human. Using the whole-cell patch-clamp technique under voltage-clamp, IAB (evoked by voltage steps or ramps) was found to be time-independent, outwardly rectifying and highly permeable to NO3-, with a relative permeability sequence of NO3->I->Cl-. Further studies showed that IAB was insensitive to PKA and PKC inhibition, cell-shrinkage, intracellular Ca2+ chelation and GTP-γ-S as well as two widely used chloride channel blockers such as DIDS and clomiphene. In order to investigate the potential of IAB as a pharmacological target for regulating the ventricular AP, the effects of four pyrethroid agents α-cypermethrin (CYP), fenpropathrin (FENP), tefluthrin (TEF) and tetramethrin (TET) were investigated on IAB. FENP, CYP and TEF significantly increased the magnitude of IAB with EC50s of ~3 µM, ~7 µM and ~4 µM, respectively, while TET was ineffective. FENP also inhibited the volume-regulated chloride current with an IC50 of ~26 µM. None of the pyrethroids tested affected the cardiac cyclic AMP-activated chloride current. Taken collectively, these results suggest that IAB in guinea pig ventricular myocytes, possesses biophysical and pharmacological properties distinct from the three major classes of cardiac chloride conductances commonly reported. Under current-clamp, APs were shortened by ~21 % when extracellular Cl- was substituted with NO3-. Similarly, 10 µM TEF shortened APs by ~21 %. Mathematical simulations used to examine the potential role of IAB in regulating AP repolarisation revealed that IAB (when incorporated into a guinea pig ventricular cell model) shortened APD. Collectively these findings provide strong evidence that IAB in guinea pig ventricular myocytes, regulates AP repolarisation and that its inhibition may represent a novel Class III approach to treat arrhythmias.